WebOct 18, 2024 · CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced that shareholders will receive proxy material beginning this week from the Company in connection with its upcoming 2024 … WebOct 21, 2024 · CytoDyn recently filed with the SEC a definitive proxy statement and associated blue proxy card in connection with the solicitation of proxies for the Company’s 2024 Annual Meeting.
Large shareholder group calls for a board overhaul at pharma
WebOct 8, 2024 · On October 28, 2024, the stockholders of Defendant, CytoDyn Inc. (“CytoDyn” or the “Company”), will hold their annual meeting (the “Annual Meeting”). At that meeting, among other things, the stockholders will elect the latest iteration of CytoDyn’s board of directors (the “Board”). CytoDyn’s bylaws require WebOct 14, 2024 · Sidley has represented CytoDyn and its board of directors since July 2024, when a group of dissident shareholders announced their intention to launch a proxy contest seeking to replace CytoDyn’s board of directors at … foam for flight cases
CytoDyn, anticipating a key vote, adjourns annual meeting, …
Web23 hours ago · Reuters. MILAN - Stellantis shareholders on Thursday approved the compensation package for the car maker's top management, including for CEO Carlos Tavares, after rejecting it last year. WebApr 13, 2024 · NEW YORK, April 13, 2024--Pfizer Inc. (NYSE: PFE) announced today that its shareholders and the general public are invited to access its virtual-only 2024 Annual Meeting of Shareholders at 9:00 a ... WebOct 28, 2024 · The Annual Meeting was adjourned to be held virtually on Wednesday, November 24, 2024 at 8:00 a.m. Pacific Time. The adjournment provides the Company with additional time to solicit proxies from its shareholders to achieve a quorum at … foam for fiberglass construction